Apogee Therapeutics, Inc. Common Stock (APGE) Insider Trading
- $30,740,800.00
- $16,893,123.70
- March 11, 2026
- Carl Dambkowski
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| March 11, 2026 | CEO | 20,000 | $74.78 | Sell | $1,495,600.00 | |
| March 4, 2026 | Insider | 5,500 | $71.06 | Sell | $390,830.00 | |
| Feb. 11, 2026 | CEO | 20,000 | $63.35 | Sell | $1,267,000.00 | |
| Feb. 4, 2026 | Insider | 5,500 | $65.79 | Sell | $361,845.00 | |
| Sept. 3, 2025 | Insider | 2,725 | $37.87 | Sell | $103,195.75 | |
| Aug. 6, 2025 | Insider | 2,725 | $37.78 | Sell | $102,950.50 | |
| July 2, 2025 | Insider | 10,090 | $45.09 | Sell | $454,958.10 | |
| June 4, 2025 | Insider | 2,725 | $36.96 | Sell | $100,716.00 | |
| May 7, 2025 | Insider | 2,725 | $35.75 | Sell | $97,418.75 | |
| April 2, 2025 | Insider | 3,860 | $36.22 | Sell | $139,809.20 | |
| March 5, 2025 | CEO | 10,000 | $30.15 | Sell | $301,500.00 | |
| March 5, 2025 | Insider | 1,590 | $30.48 | Sell | $48,463.20 | |
| Feb. 5, 2025 | Insider | 3,520 | $40.69 | Sell | $143,228.80 | |
| Feb. 5, 2025 | CEO | 15,000 | $40.58 | Sell | $608,700.00 | |
| Jan. 8, 2025 | CEO | 15,000 | $48.85 | Sell | $732,750.00 | |
| Jan. 2, 2025 | Insider | 4,085 | $46.94 | Sell | $191,749.90 | |
| Dec. 12, 2024 | Director | 20,000 | $49.54 | Buy | $990,800.00 | |
| Dec. 11, 2024 | Insider | 4,540 | $48.76 | Sell | $221,370.40 | |
| Dec. 4, 2024 | CEO | 15,000 | $46.58 | Sell | $698,700.00 | |
| Dec. 4, 2024 | Insider | 6,665 | $46.07 | Sell | $307,056.55 | |
| Nov. 6, 2024 | Insider | 6,665 | $59.12 | Sell | $394,034.80 | |
| Nov. 6, 2024 | CEO | 15,000 | $59.22 | Sell | $888,300.00 | |
| Oct. 2, 2024 | CEO | 40,000 | $56.23 | Sell | $2,249,200.00 | |
| Oct. 2, 2024 | Insider | 6,665 | $56.26 | Sell | $374,972.90 | |
| Sept. 4, 2024 | Insider | 6,665 | $47.56 | Sell | $316,987.40 | |
| Sept. 4, 2024 | CEO | 40,000 | $47.62 | Sell | $1,904,800.00 | |
| Aug. 23, 2024 | CFO | 6,000 | $48.26 | Sell | $289,560.00 | |
| Aug. 7, 2024 | CEO | 40,000 | $40.62 | Sell | $1,624,800.00 | |
| Aug. 7, 2024 | Insider | 7,335 | $40.67 | Sell | $298,314.45 | |
| July 5, 2024 | CEO | 15,000 | $37.26 | Sell | $558,900.00 | |
| July 3, 2024 | Insider | 5,995 | $37.60 | Sell | $225,412.00 | |
| July 13, 2023 | Director | 1,750,000 | $17.00 | Buy | $29,750,000.00 |
Insiders are both buying and selling Apogee Therapeutics, Inc. Common Stock stock.
The insider traders at Apogee Therapeutics, Inc. Common Stock are: Carl Dambkowski, Michael Thomas Henderson, Jane Henderson, Mark C Mckenna, and Nimish P Shah
The most active insider trader at Apogee Therapeutics, Inc. Common Stock is Carl Dambkowski with 18 trades.
Michael Thomas Henderson has sold the most Apogee Therapeutics, Inc. Common Stock stock with a total value of $13,825,850.00.
Nimish P Shah has bought the most Apogee Therapeutics, Inc. Common Stock stock with a total value of $59,500,000.00.
The most recent insider trade for Apogee Therapeutics, Inc. Common Stock was on March 11, 2026.
The single biggest insider buy for Apogee Therapeutics, Inc. Common Stock was from Nimish P Shah with a total value of $29,750,000.00 on July 13, 2023.
The single biggest insider sell for Apogee Therapeutics, Inc. Common Stock was from Michael Thomas Henderson with a total value of $2,249,200.00 on Oct. 2, 2024.